3-7 July 2023
University of Zululand
Africa/Johannesburg timezone
The Proceedings of SAIP2023 Published: 20 December 2023

Curcumin an emerging natural photosensitiser for lung cancer photodynamic therapy

4 Jul 2023, 10:00
20m
University of Zululand

University of Zululand

Oral Presentation Track C - Photonics Photonics

Speaker

Glory Kah (University of Johannesburg)

Description

G Kah, R Chandran and H Abrahamse

Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein 2028, South Africa.

Email: rahulc@uj.ac.za

Abstract. Worldwide, lung cancer remains the main cause of malignant tumours and it contributes to a high mortality rate in cancer cases. Conventional therapeutic approaches for lung cancer are characterised as ineffective since resistance to therapy and toxic after-effects do occur in patients. Photodynamic therapy (PDT) is a promising therapeutic approach that requires a specific light source for the activation of a photosensitiser to induce cytotoxic cell death via the generation of reactive oxygen species. Curcumin is a natural compound from Curcuma longa that has been confirmed as a photosensitiser. This study aims to investigate the in vitro effects of curcumin-mediated PDT of lung cancer. Lung cancer cell lines (A549) were grown in complete media in an incubator maintained at 85% humidity, 5% CO2, and a temperature of 37°C. Treatment of cells was achieved by exploring different concentrations of curcumin, and the cells were irradiated with a 470 nm diode laser at 5 J/cm2 fluency. Post-PDT tests including microscopic evaluation of treated cells and biochemical analysis were performed to determine the cellular response of cells treated. The results revealed morphological alterations and decreased viability in treated cells, which signifies cytotoxic damage. Thus, the increased cytotoxic effect established in this study suggests that curcumin can be an effective natural photosensitiser over synthetic ones for mediating lung cancer PDT. Further in vivo studies may be needed to evaluate how curcumin can be utilized for lung cancer PDT in clinical settings.

Level for award;(Hons, MSc, PhD, N/A)?

PhD

Apply to be considered for a student ; award (Yes / No)? Yes

Primary author

Glory Kah (University of Johannesburg)

Co-authors

Prof. Heide Abrahamse (University of Johannesburg) Dr Rahul Chandran (University of Johannesburg)

Presentation Materials

Peer reviewing

Paper